|
ES2346178T3
(es)
*
|
2007-07-31 |
2015-11-02 |
Affibody Ab |
Nuevas composiciones, procedimientos y usos de unión de la albúmina
|
|
US20120134984A1
(en)
*
|
2009-06-01 |
2012-05-31 |
Olga Lubman |
Molecules with extended half-lives and uses thereof
|
|
JP5951509B2
(ja)
*
|
2010-03-08 |
2016-07-13 |
ジーイー・ヘルスケア・バイオサイエンス・アクチボラグ |
免疫グロブリンＧＦｃ領域結合ポリペプチド
|
|
CA2793715A1
(en)
*
|
2010-04-30 |
2011-11-03 |
Sanwa Kagaku Kenkyusho Co., Ltd. |
Peptide for improving in vivo stability of physiologically active substance or the like and physiologically active substance with improved in vivo stability
|
|
KR101884654B1
(ko)
|
2010-07-09 |
2018-08-02 |
애피바디 에이비 |
폴리펩타이드
|
|
SG187682A1
(en)
*
|
2010-08-02 |
2013-03-28 |
Macrogenics Inc |
Covalent diabodies and uses thereof
|
|
CA2813087C
(en)
|
2010-09-28 |
2020-07-21 |
Amylin Pharmaceuticals, Llc |
Engineered polypeptides having enhanced duration of action
|
|
JP6121330B2
(ja)
|
2010-09-28 |
2017-04-26 |
アミリン・ファーマシューティカルズ, リミテッド・ライアビリティ・カンパニーAmylin Pharmaceuticals, Llc |
作用持続時間が増した改変ポリペプチド
|
|
US9284361B2
(en)
|
2010-11-26 |
2016-03-15 |
Molecular Partners Ag |
Designed repeat proteins binding to serum albumin
|
|
CA2836873C
(en)
*
|
2011-05-21 |
2019-10-22 |
Macrogenics, Inc. |
Deimmunized serum-binding domains and their use for extending serum half-life
|
|
CN103957926B
(zh)
*
|
2011-07-08 |
2018-07-03 |
安米林药品有限责任公司 |
具有增强的作用持续时间和降低的免疫原性的工程改造的多肽
|
|
JP6006309B2
(ja)
*
|
2011-07-08 |
2016-10-12 |
アミリン・ファーマシューティカルズ, リミテッド・ライアビリティ・カンパニーAmylin Pharmaceuticals, Llc |
作用持続期間が増大し、免疫原性が減少した操作されたポリペプチド
|
|
SMT201900189T1
(it)
|
2012-02-20 |
2019-05-10 |
Swedish Orphan Biovitrum Ab Publ |
Polipeptidi che si legano al c5 del complemento umano
|
|
JP2020033372A
(ja)
*
|
2012-03-28 |
2020-03-05 |
アフィボディ・アーベー |
経口投与
|
|
EP2844269A4
(en)
*
|
2012-03-28 |
2016-01-06 |
Amylin Pharmaceuticals Llc |
TRANSMUCOSAL ADMINISTRATION OF MANIPULATED POLYPEPTIDES
|
|
EP2830665A1
(en)
|
2012-03-28 |
2015-02-04 |
Affibody AB |
Oral administration
|
|
WO2013177398A2
(en)
|
2012-05-25 |
2013-11-28 |
Janssen Biotech, Inc. |
Non-natural consensus albumin binding domains
|
|
KR102123457B1
(ko)
*
|
2012-09-25 |
2020-06-16 |
애피바디 에이비 |
알부민 결합 폴리펩타이드
|
|
CN104768976B
(zh)
|
2012-10-05 |
2020-09-22 |
阿菲博迪公司 |
Her3结合多肽
|
|
PL2912051T3
(pl)
*
|
2012-10-25 |
2018-08-31 |
Affibody Ab |
Sposób rozdzielania białek zawierających domenę wiążącą albuminę
|
|
DK2912054T3
(en)
*
|
2012-10-25 |
2017-09-11 |
Affibody Ab |
Albumin-binding polypeptide
|
|
WO2014076179A1
(en)
|
2012-11-14 |
2014-05-22 |
Affibody Ab |
New polypeptide
|
|
US9255262B2
(en)
|
2013-03-06 |
2016-02-09 |
Vision Global Holdings Ltd. |
Albumin-binding arginine deminase and the use thereof
|
|
USRE48805E1
(en)
|
2013-03-06 |
2021-11-02 |
Vision Global Holdings Ltd. |
Method for cancer targeting treatment and detection of arginine using albumin-binding arginine deiminase fusion protein
|
|
CA2902789A1
(en)
|
2013-03-14 |
2014-09-18 |
The Governing Council Of The University Of Toronto |
Scaffolded peptidic libraries and methods of making and screening the same
|
|
RU2015142437A
(ru)
|
2013-03-14 |
2017-04-27 |
Дайити Санкио Ко., Лтд |
Новые связывающие белки для pcsk9
|
|
CA2902657C
(en)
|
2013-03-15 |
2022-05-10 |
Affibody Ab |
Fcrn binding polypeptides
|
|
HK1215681A1
(zh)
|
2013-04-18 |
2016-09-09 |
Armo Biosciences, Inc. |
使用白细胞介素-10治疗疾病和病症的方法
|
|
ES2688206T3
(es)
|
2013-06-17 |
2018-10-31 |
Armo Biosciences, Inc. |
Procedimiento de evaluación de la identidad y la estabilidad de proteínas
|
|
DK3038633T3
(da)
|
2013-08-28 |
2021-01-11 |
Ipc Res Llc |
Stabile polypeptider der binder til human komplement c5
|
|
ES2742505T3
(es)
|
2013-08-28 |
2020-02-14 |
Affibody Ab |
Polipéptidos de unión que tienen un andamio mutado
|
|
CN105658232A
(zh)
|
2013-08-30 |
2016-06-08 |
阿尔莫生物科技股份有限公司 |
使用白细胞介素-10治疗疾病和病症的方法
|
|
ES2862139T3
(es)
|
2013-11-11 |
2021-10-07 |
Armo Biosciences Inc |
Procedimientos de uso de Interleucina 10 para el tratamiento de enfermedades y trastornos
|
|
US10167322B2
(en)
|
2013-12-20 |
2019-01-01 |
Affibody Ab |
Engineered albumin binding polypeptide
|
|
US10293043B2
(en)
|
2014-06-02 |
2019-05-21 |
Armo Biosciences, Inc. |
Methods of lowering serum cholesterol
|
|
UA123432C2
(uk)
|
2014-07-30 |
2021-04-07 |
Нджм Біофармасьютікалз, Інк. |
Димер та спосіб його застосування для лікування метаболічних розладів
|
|
US10323066B2
(en)
|
2014-09-17 |
2019-06-18 |
Affibody Ab |
Neonatal Fc receptor binding dimer and methods of use
|
|
KR20170068553A
(ko)
|
2014-10-14 |
2017-06-19 |
아르모 바이오사이언시스 인코포레이티드 |
인터류킨-15 조성물 및 이의 용도
|
|
MX2017004983A
(es)
|
2014-10-22 |
2017-11-13 |
Armo Biosciences Inc |
Metodos para usar interleucina 10 para tratar enfermedades y trastornos.
|
|
ES2799503T3
(es)
|
2014-10-31 |
2020-12-18 |
Ngm Biopharmaceuticals Inc |
Composiciones y procedimientos de uso para el tratamiento de trastornos metabólicos
|
|
DK3245224T3
(da)
|
2015-01-12 |
2020-09-21 |
Affibody Ab |
Il-17a-bindende polypeptider
|
|
US10618970B2
(en)
|
2015-02-03 |
2020-04-14 |
Armo Biosciences, Inc. |
Method of treating cancer with IL-10 and antibodies that induce ADCC
|
|
US11052133B2
(en)
|
2015-05-06 |
2021-07-06 |
Protomer Technologies, Inc. |
Glucose responsive insulins
|
|
HK1248137A1
(zh)
|
2015-05-28 |
2018-10-12 |
阿尔莫生物科技股份有限公司 |
用於治疗癌症的聚乙二醇化白细胞介素-10
|
|
CN108463244B
(zh)
|
2015-08-04 |
2022-05-27 |
杜克大学 |
用于递送的基因编码的固有无序隐形聚合物及其使用方法
|
|
MX2018002298A
(es)
|
2015-08-25 |
2018-07-06 |
Armo Biosciences Inc |
Metodos de uso de interleucina 10 para el tratamiento de enfermedades y trastornos.
|
|
US11752213B2
(en)
|
2015-12-21 |
2023-09-12 |
Duke University |
Surfaces having reduced non-specific binding and antigenicity
|
|
CN107022031A
(zh)
*
|
2016-01-29 |
2017-08-08 |
中国人民解放军军事医学科学院微生物流行病研究所 |
融合蛋白HSA1-Vβ1及其应用
|
|
WO2017210476A1
(en)
|
2016-06-01 |
2017-12-07 |
Duke University |
Nonfouling biosensors
|
|
CN110023326A
(zh)
|
2016-09-23 |
2019-07-16 |
杜克大学 |
具有lcst行为的非结构化无重复多肽
|
|
CN107952080A
(zh)
*
|
2016-10-14 |
2018-04-24 |
中国科学院过程工程研究所 |
一种肿瘤靶向多肽-药物偶联衍生物、其制备方法及应用
|
|
US11648200B2
(en)
|
2017-01-12 |
2023-05-16 |
Duke University |
Genetically encoded lipid-polypeptide hybrid biomaterials that exhibit temperature triggered hierarchical self-assembly
|
|
WO2018213320A1
(en)
|
2017-05-15 |
2018-11-22 |
Duke University |
Recombinant production of hybrid lipid-biopolymer materials that self-assemble and encapsulate agents
|
|
US11680083B2
(en)
|
2017-06-30 |
2023-06-20 |
Duke University |
Order and disorder as a design principle for stimuli-responsive biopolymer networks
|
|
WO2019032827A1
(en)
*
|
2017-08-09 |
2019-02-14 |
Massachusetts Institute Of Technology |
PEPTIDE ALBUMIN BINDING CONJUGATES AND METHODS THEREOF
|
|
US20200239575A1
(en)
*
|
2017-10-06 |
2020-07-30 |
University Of Utah Research Foundation |
A fusion protein for targeted therapy of autoimmune disease
|
|
WO2019071150A1
(en)
*
|
2017-10-06 |
2019-04-11 |
University Of Utah Research Foundation |
FUSION PROTEIN FOR TARGETED THERAPY OF AUTOIMMUNE DISEASE
|
|
WO2019147954A1
(en)
*
|
2018-01-26 |
2019-08-01 |
Duke University |
Albumin binding peptide-drug (aibiped) conjugates and methods of making and using same
|
|
EP3765496A1
(en)
|
2018-03-13 |
2021-01-20 |
Affibody AB |
Polypeptides based on a novel scaffold
|
|
WO2019213150A1
(en)
|
2018-04-30 |
2019-11-07 |
Duke University |
Stimuli-responsive peg-like polymer-based drug delivery platform
|
|
WO2020028806A1
(en)
|
2018-08-02 |
2020-02-06 |
Duke University |
Dual agonist fusion proteins
|
|
WO2020051541A1
(en)
*
|
2018-09-07 |
2020-03-12 |
Duke University |
Nanoparticulate drug delivery systems
|
|
WO2020176478A1
(en)
|
2019-02-25 |
2020-09-03 |
The University Of Chicago |
Methods and compositions for treating inflammatory and autoimmune conditions with ecm-affinity peptides linked to anti-inflammatory agents
|
|
CA3138805A1
(en)
|
2019-06-04 |
2020-12-10 |
Johannes Schilling |
Designed ankyrin repeat domain with improved stability
|
|
US11512314B2
(en)
|
2019-07-12 |
2022-11-29 |
Duke University |
Amphiphilic polynucleotides
|
|
EP3785726A1
(en)
|
2019-09-02 |
2021-03-03 |
Biotest AG |
Factor viii protein with increased half-life
|
|
JP2022546525A
(ja)
|
2019-09-02 |
2022-11-04 |
ビオテスト・アクチエンゲゼルシャフト |
延長された半減期を有する第ｖｉｉｉ因子タンパク質
|
|
US20220389066A1
(en)
|
2019-11-05 |
2022-12-08 |
Affibody Ab |
Polypeptides
|
|
US20230190881A1
(en)
|
2020-02-17 |
2023-06-22 |
Biotest Ag |
Subcutaneous administration of factor viii
|
|
EP3878515A1
(en)
*
|
2020-03-09 |
2021-09-15 |
Hober Biotech AB |
Therapeutic agent targeting her2
|
|
WO2022098743A1
(en)
|
2020-11-03 |
2022-05-12 |
Indi Molecular, Inc. |
Compositions, imaging, and therapeutic methods targeting folate receptor 1 (folr1)
|
|
WO2022098745A1
(en)
|
2020-11-03 |
2022-05-12 |
Indi Molecular, Inc. |
Compositions, delivery systems, and methods useful in tumor therapy
|
|
KR20230123989A
(ko)
|
2020-12-21 |
2023-08-24 |
애피바디 에이비 |
신규 폴리펩티드
|
|
JP2024506070A
(ja)
|
2021-02-15 |
2024-02-08 |
アフィボディ アクティエボラーグ |
新規ｈｅｒ２結合ポリペプチド
|
|
KR20240139058A
(ko)
|
2022-02-08 |
2024-09-20 |
애피바디 에이비 |
흉선 기질 림포포이에틴에 결합하는 단백질 z 변이체 및 이의 의학적 용도
|
|
EP4525919A1
(en)
|
2022-05-18 |
2025-03-26 |
Protomer Technologies Inc. |
Aromatic boron-containing compounds and related insulin analogs
|
|
EP4570834A1
(en)
|
2022-08-10 |
2025-06-18 |
Kowa Company, Ltd. |
Affibody micelle drug conjugate
|
|
CN120712282A
(zh)
|
2023-02-17 |
2025-09-26 |
阿布林克斯有限公司 |
结合新生儿fc受体的多肽
|
|
WO2024227930A1
(en)
|
2023-05-04 |
2024-11-07 |
Affibody Ab |
New polypeptide
|
|
WO2025073871A1
(en)
|
2023-10-03 |
2025-04-10 |
Bicycletx Limited |
Bicyclic peptide ligand complexes specific for tfr1
|
|
WO2025158010A1
(en)
|
2024-01-25 |
2025-07-31 |
Affibody Ab |
Her2-binding polypeptide
|
|
CN118666961B
(zh)
*
|
2024-08-23 |
2024-11-26 |
通化安睿特生物制药股份有限公司 |
人白蛋白特异结合多肽及其应用
|